Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,838 | -15,015 | 5,269 | 4,218 | 2,466 |
| Depreciation Amortization | 411 | 47 | 90 | 84 | 30 |
| Accounts payable and accrued liabilities | -1,204 | 244 | N/A | N/A | N/A |
| Other Working Capital | -4,250 | 535 | 81 | 331 | 383 |
| Other Operating Activity | 5,295 | 12,612 | -7,916 | -7,230 | -4,452 |
| Operating Cash Flow | $-9,586 | $-1,577 | $-2,476 | $-2,597 | $-1,573 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -14 | -504 | -434 | -315 |
| Investing Cash Flow | $-14 | $-14 | $-504 | $-434 | $-315 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 10,100 | 10,100 | 10,100 |
| Debt Repayment | -159 | -13 | -48 | -35 | -23 |
| Common Stock Issued | 4,992 | 4 | 15 | 15 | 1 |
| Other Financing Activity | 3,262 | 2,737 | 0 | 0 | 0 |
| Financing Cash Flow | $8,095 | $2,728 | $10,067 | $10,080 | $10,078 |
| Beginning Cash Position | 7,619 | 7,619 | 532 | 532 | 532 |
| End Cash Position | 6,114 | 8,756 | 7,619 | 7,581 | 8,722 |
| Net Cash Flow | $-1,505 | $1,137 | $7,087 | $7,049 | $8,190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,586 | -1,577 | -2,476 | -2,597 | -1,573 |
| Capital Expenditure | -14 | -14 | -504 | -434 | -315 |
| Free Cash Flow | -9,600 | -1,591 | -2,980 | -3,031 | -1,888 |